isoproterenol has been researched along with Cancer of Ovary in 6 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Isoproterenol treatment resulted in a significant increase in tumor volume and infiltration in the SKOV3ip1 in vivo model, which was blocked by propranolol." | 1.33 | Stress hormone-mediated invasion of ovarian cancer cells. ( Bhatty, R; Cole, SW; Gershenson, DM; Han, L; Kamat, AA; Landen, CN; Li, Y; Lutgendorf, S; Sood, AK; Thaker, PH, 2006) |
| " isoprenaline was selectively depressed by doxorubicin (no changes in chronotropic responses) and this adverse effect of doxorubicin was also prevented in zofenopril+doxorubicin pretreated rats." | 1.31 | Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat. ( Bigioni, M; Evangelista, S; Goso, C; Maggi, CA; Manzini, S; Sacco, G, 2001) |
| " In this study, both LMF and Zn-alpha2-glycoprotein have been shown to stimulate glycerol release from isolated murine epididymal adipocytes with a comparable dose-response profile." | 1.30 | Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. ( Barber, MD; Hirai, K; Hussey, HJ; Price, SA; Tisdale, MJ, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 5 (83.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rangarajan, S | 1 |
| Enserink, JM | 1 |
| Kuiperij, HB | 1 |
| de Rooij, J | 1 |
| Price, LS | 1 |
| Schwede, F | 1 |
| Bos, JL | 1 |
| Lutgendorf, SK | 2 |
| Cole, S | 1 |
| Costanzo, E | 1 |
| Bradley, S | 1 |
| Coffin, J | 1 |
| Jabbari, S | 1 |
| Rainwater, K | 1 |
| Ritchie, JM | 1 |
| Yang, M | 1 |
| Sood, AK | 3 |
| Bhatty, R | 1 |
| Kamat, AA | 2 |
| Landen, CN | 2 |
| Han, L | 1 |
| Thaker, PH | 2 |
| Li, Y | 2 |
| Gershenson, DM | 2 |
| Lutgendorf, S | 1 |
| Cole, SW | 2 |
| Han, LY | 1 |
| Arevalo, JM | 1 |
| Takahashi, R | 1 |
| Lu, C | 1 |
| Jennings, NB | 1 |
| Armaiz-Pena, G | 1 |
| Bankson, JA | 1 |
| Ravoori, M | 1 |
| Merritt, WM | 1 |
| Lin, YG | 1 |
| Mangala, LS | 1 |
| Kim, TJ | 1 |
| Coleman, RL | 1 |
| Felix, E | 1 |
| Sanguino, AM | 1 |
| Newman, RA | 1 |
| Lloyd, M | 1 |
| Kundra, V | 1 |
| Lopez-Berestein, G | 1 |
| Hirai, K | 1 |
| Hussey, HJ | 1 |
| Barber, MD | 1 |
| Price, SA | 1 |
| Tisdale, MJ | 1 |
| Sacco, G | 1 |
| Bigioni, M | 1 |
| Evangelista, S | 1 |
| Goso, C | 1 |
| Manzini, S | 1 |
| Maggi, CA | 1 |
6 other studies available for isoproterenol and Cancer of Ovary
| Article | Year |
|---|---|
Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adrenergic beta-Agonists; Carcinoma; Cell Adhesion; Cyclic A | 2003 |
Stress-related mediators stimulate vascular endothelial growth factor secretion by two ovarian cancer cell lines.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Anti-Inflammatory Agents; Epinephrine; Female; | 2003 |
Stress hormone-mediated invasion of ovarian cancer cells.
Topics: Animals; Enzyme-Linked Immunosorbent Assay; Epinephrine; Female; Humans; Hydrocortisone; Isoproteren | 2006 |
Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma.
Topics: Animals; Carcinoma; Cell Line, Tumor; Disease Models, Animal; Drug Combinations; Enzyme Inhibitors; | 2006 |
Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients.
Topics: Adenylyl Cyclases; Adipocytes; Adrenergic beta-Agonists; Animals; Body Composition; Cachexia; Cells, | 1998 |
Cardioprotective effects of zofenopril, a new angiotensin-converting enzyme inhibitor, on doxorubicin-induced cardiotoxicity in the rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antineoplastic Agents; Body Weight; Captopril; Ca | 2001 |